Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Glucagon like peptide 2 (GLP-2)

Tools
- Tools
+ Tools

Dimitriadis, Georgios K. and Miras, Alexander D. (2018) Glucagon like peptide 2 (GLP-2). In: Huhtaniemi, Ilpo, (ed.) Encyclopedia of Endocrine Diseases. Elsevier Academic Press, pp. 561-564. ISBN 9780128122006

[img] Microsoft Word (GLP-2 book chapter)
Glucagon Peptide 2 (GLP-2) Encyclopedia of Endocrine Diseases FINAL.docx - Accepted Version
Embargoed item. Restricted access to Repository staff only

Download (57Kb)
Official URL: https://doi.org/10.1016/B978-0-12-801238-3.95879-3

Request Changes to record.

Abstract

The role of the gastrointestinal (GI) tract in energy homeostasis through the digestion and absorption of carbohydrates, and the production of incretin hormones remains well recognized in recent years. Studying the functional changes of the GI system following bariatric surgery; particularly involving the secretion of incretin hormones has led into understanding their interaction with arears of the brain to regulate metabolism and energy balance. In Type 2 Diabetes Mellitus (T2DM) and obesity, this homeostatic balance is disrupted, either through alterations in the levels of these hormones or through resistance to their actions. Although bariatric surgery is an effective treatment for T2DM and obesity, it cannot be applied to most patients. Hence, recapitulation of the changes of incretin hormone secretion after bariatric surgery in the post Glucagon-like peptide 1 (GLP-1) analogue era remains an attractive area for further research and the development of new treatments for T2DM and obesity.
Glucagon-like peptide 2 (GLP-2) is a proglucagon-derived peptide produced by intestinal L-cells and by cells within the brainstem and other areas of the central nervous system. GLP-2 is implicated in regulation of energy absorption and maintenance of GI mucosal structure but as recent evidence suggests may also have a beneficial effect in glucose homeostasis, particularly in states associated with increased energy uptake such as obesity.

Item Type: Book Item
Subjects: Q Science > QP Physiology
R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
Divisions: Faculty of Medicine > Warwick Medical School > Biomedical Sciences
Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016)
Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine
Faculty of Medicine > Warwick Medical School
Publisher: Elsevier Academic Press
ISBN: 9780128122006
Book Title: Encyclopedia of Endocrine Diseases
Editor: Huhtaniemi, Ilpo
Official Date: 1 October 2018
Dates:
DateEvent
1 October 2018Published
Volume: 1
Number of Pages: 4000
Page Range: pp. 561-564
DOI: 10.1016/B978-0-12-801238-3.95879-3
Status: Peer Reviewed
Publication Status: Published
Related URLs:
  • Publisher

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us